TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

SANOFI-AVENTIS U.S. LLC

MetabolicOncologyRespiratory
Biotech

SANOFI-AVENTIS U.S. LLC is a biotechnology company focused on Metabolic, Oncology, Respiratory.

2025
Since
2
Drugs
-
Trials
1
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

MERILOG 2025-02-14
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Metabolic 36%
2 drugs Phase 3: 26 Phase 2: 7 Phase 1: 50
Oncology 21%
0 drugs Phase 3: 8 Phase 2: 21 Phase 1: 34
Respiratory 17%
0 drugs Phase 3: 14 Phase 2: 11 Phase 1: 8
Immunology 14%
0 drugs Phase 3: 7 Phase 2: 16 Phase 1: 9
Neurology 12%
0 drugs Phase 3: 11 Phase 2: 5 Phase 1: 8

Pipeline Strength Pro

Loading...

Competitors Pro

GSK big-pharma
Respiratory, Oncology, Immunology, Neurology
Sanofi big-pharma
Metabolic, Oncology, Immunology, Respiratory
Eli Lilly big-pharma
Metabolic, Oncology, Immunology, Neurology
Roche big-pharma
Oncology, Neurology, Immunology, Respiratory
AstraZeneca big-pharma
Oncology, Respiratory, Metabolic, Immunology